Neuro-oncology evaluation
| Laboratory test | Value | Normal | Units |
|---|---|---|---|
| Blood | |||
| TSH | 2.11 | 0.55–4.78 | mcIU/mL |
| CK | 91 | 49–397 | Unit/L |
| WBC | 11.7 | 4.2–9.1 | K/uL |
| Vitamin B12 | 587 | 211–911 | Pg/mL |
| CSF | |||
| Initial | |||
| WBC | 1 | 0–5 | Cells/uL |
| RBC | 0 | 0 | Cells/uL |
| Protein | > 300 | 15–45 | Mg/dL |
| Glucose | 73 | 40–70 | Mg/dL |
| Cytology | Negative for malignant cells | ||
| 6 month Follow-up | |||
| WBC | 3 | 0–5 | Cells/uL |
| RBC | 6 | 0 | Cells/uL |
| Protein | 169 | 15–45 | Mg/dL |
| Glucose | 56 | 40–70 | Mg/dL |
| Cytology | atypical cells with hyperchromatic nuclei and pigmentation, suspicious for melanoma | ||
| Autoimmune Studies | |||
| Asialo-GM1 (IgG/IgM) | 13 | 0–50 | IV |
| GM2 (IgG/IgM) | 4 | 0–50 | IV |
| GD1a (IgG/IgM) | 8 | 0–50 | IV |
| GD1b (IgG/IgM) | 4 | 0–50 | IV |
| GQ1b (IgG/IgM) | 5 | 0–50 | IV |
| GM-1 (IgG) | 3 | 0–50 | IV |
| GM-1 (IgM) | 5 | 0–50 | IV |
| AMA | 1.5 | 0–20 | Units |
| Rheumatoid Factor | < 20 | < 20 | IU/mL |
| ANCA | < 1:20 | < 1:20 | |
| dsDNA antibody | Negative | ||
| ENA | Negative | ||
| Borrelia burgdorferi antibody | 0.20 | 0–1.20 | LIV |
| Leishmania antibody IgG | 0 | 0 | units |
| Hepatitis panel | |||
| Hepatitis B surface antigen | Negative | ||
| Hepatitis B surface antibody | 0.04a | mIU/mL | |
| Hepatitis B core antibody | Negative | ||
| Hepatitis C antibody | Negative | ||
| Viral studies | |||
| CMV antibody | Positive | ||
| EBV nuclear antigen | Positive | ||
| EBV viral capsid antigen IgG | Positive | ||
| EBV viral capsid antigen IgM | Negative | ||
| HIV | Negative | ||
| Herpes 1 IgG | Negative | ||
| Herpes 2 IgG | Negative | ||
Abbreviations: TSH thyroid stimulating hormone, CK creatinine kinase, WBC white blood cell, RBC red blood cell, GM monosialoganglioside, GD disialoganglioside, GQ tetrasialoganglioside, ENA extractable nuclear antigen screen, ANCA anti-neutrophil cytoplasmic antibody, dsDNA double stranded DNA, AMA Mitochondrial M2 antibody IgG, CMV Cytomegalovirus, EBV Epstein-Barr virus, HIV human immunodeficiency virus, IV index value, LIV Lyme index value
aHepatitis B surface antibody < 8 mIU/mL indicates inadequate antibody response to vaccination